Revenue projections that fall short of market estimates typically lead to negative investor sentiment in the short term, potentially causing a decrease in stock price. Given that Tandem Diabetes Care's projected revenue is significantly below the estimated figure, this could lead to a decrease in investor confidence and a potential short-term drop in the stock price.